The patient's voice is important in analyzing and evaluating the effectiveness of care, as well as in assessing the value of new treatments, said Stephen Edge, MD, FACS, FASCO, vice president of Healthcare Outcomes and Policy at Roswell Park Cancer Institute.
The patient's voice is important in analyzing and evaluating the effectiveness of care, as well as in assessing the value of new treatments, said Stephen Edge, MD, FACS, FASCO, vice president of Healthcare Outcomes and Policy at Roswell Park Cancer Institute.
Transcript
How are patient reported outcomes becoming of growing importance in the transition to value-based care?
People are recognizing a couple of things—the voice of the patient is really important in analyzing and evaluating the effectiveness of care. They're also recognizing that listening to patients and giving patients the opportunity to provide information during care can actually improve their outcomes of their care meaning dealing with side effects, dealing with emotional issues, and other impacts of treatment. Dealing with those things when they're occurring rather than waiting for them to come into an office where it's intimidating to give the information that actually improves the outcome. There are data that show that measuring these and feeding the information back to providers during the course of treatment actually not only improves the effectiveness of the treatment and the quality-of-life during treatment, but it actually improves survival of patients.
What role do quality metrics play in showing what strategies efficiently improve oncology healthcare?
Measures of care can be used for a number of different things. Measures can be used to evaluate whether the care that you received is the appropriate care—that's the obvious thing; but measures can also be used to evaluate how you are doing with your treatment and to intervene so that you can improve the treatment that you're receiving and deal with side effects of the treatment you'll be giving. Organizations from ASCO to the American College of Surgeons, to all the professional organizations going up through national organizations, including the National Quality Forum, are using these measures to both evaluate the care that's being given and to help patients and their providers ensure that they're getting the best care and they're dealing with the problems associated with those care. Furthermore, these measures will help in assessing the value of care when one's doing the value assessment of a new treatment. New treatments are very expensive–there’s a lot of new treatments becoming available and the patient's voice will become important in assessing the value of these new treatments.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More